{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:31:11Z","timestamp":1790267471673,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dengue viruses (DENVs) and Japanese encephalitis virus (JEV) are closely related mosquito-borne flaviviruses that cause very high global disease burdens. Although cross-reactivity and cross-protection within flaviviruses have been demonstrated, the effect of JEV vaccination on susceptibility to DENV infection has not been well elucidated. In this study, we found that vaccination with the JEV inactivated vaccine (INV) and live attenuated vaccine (LAV) could induce cross-immune responses and cross-protection against DENV1-4 in mice. Despite the theoretical risk of immune enhancement, no increased mortality was observed in our mouse model. Additionally, low but consistently detectable cross-neutralizing antibodies against DENV2 and DENV3 were also observed in the sera of JEV vaccine-immunized human donors. The results suggested that both JEV-LAV and JEV-INV could elicit strong cross-immunity and protection against DENVs, indicating that inoculation with JEV vaccines may influence the distribution of DENVs in co-circulated areas and that the cross-protection induced by JEV vaccines against DENVs might provide important information in terms of DENV prevention.<\/jats:p>","DOI":"10.1038\/srep19953","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T10:19:07Z","timestamp":1453976347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Jieqiong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,28]]},"reference":[{"key":"BFsrep19953_CR1","unstructured":"Centers for Disease Control (CDC). Dengue hemorrhagic fever\u2013Puerto Rico. MMWR Morb Mortal Wkly Rep. 35, 779\u2013782 (1986)."},{"key":"BFsrep19953_CR2","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1073\/pnas.91.7.2395","volume":"91","author":"TP Monath","year":"1994","unstructured":"Monath, T. P. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA 91, 2395\u20132400 (1994).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep19953_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/infdis\/jiq060","volume":"203","author":"SJ Thomas","year":"2011","unstructured":"Thomas, S. J. The necessity and quandaries of dengue vaccine development. J Infect Dis. 203, 299\u2013303 (2011).","journal-title":"J Infect Dis."},{"key":"BFsrep19953_CR4","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1038\/emi.2015.3","volume":"4","author":"X Jin","year":"2015","unstructured":"Jin, X., Lee, M. & Shu, J. Dengue fever in China: an emerging problem demands attention. Emerg Microbes Infect. 4, e3(2015).","journal-title":"Emerg Microbes Infect."},{"key":"BFsrep19953_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s11427-014-4782-3","volume":"57","author":"H Zhao","year":"2014","unstructured":"Zhao, H. et al. Isolation and characterization of dengue virus serotype 2 from the large dengue outbreak in Guangdong, China in 2014. Sci China Life Sci. 57, 1149\u20131155 (2014).","journal-title":"Sci China Life Sci."},{"key":"BFsrep19953_CR6","doi-asserted-by":"publisher","first-page":"e0003632","DOI":"10.1371\/journal.pntd.0003632","volume":"9","author":"O Horstick","year":"2015","unstructured":"Horstick, O., Tozan, Y. & Wilder-Smith A. Reviewing dengue: still a neglected tropical disease? PloS Negl Trop Dis. 9, e0003632 (2015).","journal-title":"PloS Negl Trop Dis."},{"key":"BFsrep19953_CR7","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.vaccine.2015.01.047","volume":"33","author":"J Dubayle","year":"2015","unstructured":"Dubayle, J. et al. Site-specific characterization of envelope protein N-glycosylation on Sanofi Pasteur\u2019s tetravalent CYD dengue vaccine. Vaccine. 33, 1360\u20131368 (2015).","journal-title":"Vaccine."},{"key":"BFsrep19953_CR8","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.vaccine.2015.02.016","volume":"33","author":"T Hunsawong","year":"2015","unstructured":"Hunsawong, T. et al. A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice. Vaccine. 33, 1702\u20131710 (2015).","journal-title":"Vaccine."},{"key":"BFsrep19953_CR9","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.vaccine.2015.01.074","volume":"33","author":"R Zuest","year":"2015","unstructured":"Zuest, R. et al. Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice. Vaccine. 33, 1474\u201382 (2015).","journal-title":"Vaccine."},{"key":"BFsrep19953_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev.ento.54.110807.090510","volume":"54","author":"AF van den Hurk","year":"2009","unstructured":"van den Hurk, A. F., Ritchie, S. A. & Mackenzie, J. S. Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol. 54, 17\u201335 (2009).","journal-title":"Annu Rev Entomol."},{"key":"BFsrep19953_CR11","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","volume":"28","author":"Y Yu","year":"2010","unstructured":"Yu, Y. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine. 28. 3635\u20133641 (2010).","journal-title":"Vaccine."},{"key":"BFsrep19953_CR12","doi-asserted-by":"publisher","first-page":"8669","DOI":"10.1016\/j.vaccine.2011.08.117","volume":"29","author":"E Schuller.","year":"2011","unstructured":"Schuller. E., Klingler, A., Dubischar-Kastner, K., Dewasthaly, S. & Muller, Z. Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R)). Vaccine. 29, 8669\u20138676 (2011).","journal-title":"Vaccine."},{"key":"BFsrep19953_CR13","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1016\/j.vaccine.2013.06.099","volume":"31","author":"JQ Li","year":"2013","unstructured":"Li, J. Q. et al. Charaterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephatilitis virus in mice. Vaccine. 31, 4136\u20134142 (2013).","journal-title":"Vaccine."},{"key":"BFsrep19953_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","volume":"1","author":"AB Sabin","year":"1952","unstructured":"Sabin, A. B. Research on dengue during World War II. Am J Trop Med Hyg. 1, 30\u201350 (1952).","journal-title":"Am J Trop Med Hyg."},{"key":"BFsrep19953_CR15","first-page":"24","volume":"243","author":"SB Halstead","year":"1973","unstructured":"Halstead, S. B., Chow, J. & Marchette, N. J. Immunologic enhancement of dengue virus replication. Nature New Biology. 243, 24\u201326 (1973).","journal-title":"Nature New Biology."},{"key":"BFsrep19953_CR16","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1016\/S0264-410X(03)00507-3","volume":"21","author":"T Takasaki","year":"2003","unstructured":"Takasaki, T. et al. Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice. Vaccine. 21, 4514\u20134518 (2003).","journal-title":"Vaccine."},{"key":"BFsrep19953_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4269\/ajtmh.2002.66.115","volume":"66","author":"NP Kanesa-Thasan","year":"2002","unstructured":"Kanesa-Thasan, N. P., Mangiafico, J. A., Saluzzo, J. E. & Ludwig, G. V. Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg. 66, 115\u2013116 (2002).","journal-title":"Am J Trop Med Hyg."},{"key":"BFsrep19953_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4269\/ajtmh.2002.66.113","volume":"66","author":"TP Monath","year":"2002","unstructured":"Monath, T. P. Editorial: jennerian vaccination against West Nile virus. Am J Trop Med Hyg. 66, 113\u2013114 (2002).","journal-title":"Am J Trop Med Hyg."},{"key":"BFsrep19953_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3201\/eid0803.010238","volume":"8","author":"RB Tesh","year":"2002","unstructured":"Tesh, R. B., Travassos da Rosa, A. P., Guzman, H., Araujo, T. P. & Xiao, S. Y. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis. 8, 245\u2013251 (2002).","journal-title":"Emerg Infect Dis."},{"key":"BFsrep19953_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/oxfordjournals.aje.a121358","volume":"94","author":"WH Price","year":"1971","unstructured":"Price, W. H. & Thind, I. S. Protection against West Nile virus induced by a previous injection with dengue virus. Am J Epidemiol. 94, 596\u2013607 (1971).","journal-title":"Am J Epidemiol."},{"key":"BFsrep19953_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3181\/00379727-135-35098a","volume":"135","author":"GE Sather","year":"1970","unstructured":"Sather, G. E. & Hammon, W. M. Protection against St. Louis encephalitis and West Nile arboviruses by previous dengue virus (types 1-4) infection. Proc Soc Exp Biol Med. 135, 573\u2013578 (1970).","journal-title":"Proc Soc Exp Biol Med."},{"key":"BFsrep19953_CR22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/iai.9.5.909-915.1974","volume":"9","author":"GC Tarr","year":"1974","unstructured":"Tarr, G. C. & Hammon, H. W. Cross-protection between group B arboviruses: resistance in mice to Japanese B encephalitis and St. Louis encephalitis viruses induce by dengue virus immunization. Infect Immun. 9, 909\u2013915 (1974).","journal-title":"Infect Immun."},{"key":"BFsrep19953_CR23","first-page":"277","volume":"36","author":"MK Goverdhan","year":"1992","unstructured":"Goverdhan, M. K., Kulkarni, A. B., Gupta, A. K., Tupe, C. D. & Rodrigues, J. J. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol, 36, 277\u2013283 (1992).","journal-title":"Acta Virol"},{"key":"BFsrep19953_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai, W. et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 328, 745\u2013748 (2010).","journal-title":"Science."},{"key":"BFsrep19953_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coviro.2012.12.001","volume":"3","author":"TC Pierson","year":"2013","unstructured":"Pierson, T. C. & Kielian, M. Flaviviruses: braking the entering. Curr Opin Virol. 3, 3\u201312 (2013).","journal-title":"Curr Opin Virol."},{"key":"BFsrep19953_CR26","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1128\/JVI.00080-06","volume":"80","author":"K Stiasny","year":"2006","unstructured":"Stiasny, K., Kiermayr, S., Holzmann, H. & Heinz, F. X. Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol. 80. 9557\u20139568 (2006).","journal-title":"J Virol."},{"key":"BFsrep19953_CR27","doi-asserted-by":"publisher","first-page":"11828","DOI":"10.1128\/JVI.00643-07","volume":"81","author":"T Oliphant","year":"2007","unstructured":"Oliphant, T. et al. Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol, 81, 11828\u201311839 (2007).","journal-title":"J Virol"},{"key":"BFsrep19953_CR28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1099\/vir.0.82640-0","volume":"88","author":"WD Crill","year":"2007","unstructured":"Crill, W. D., Trainor, N. B. & Chang, G. J. A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J Gen Virol. 88, 1169\u20131174 (2007).","journal-title":"J Gen Virol."},{"key":"BFsrep19953_CR29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.virol.2006.10.033","volume":"360","author":"NB Trainor","year":"2007","unstructured":"Trainor, N. B., Crill, W. D., Roberson, J. A. & Chang, G. J. Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein. Virology. 360, 398\u2013406 (2007).","journal-title":"Virology."},{"key":"BFsrep19953_CR30","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1128\/JVI.00316-08","volume":"82","author":"CY Lai","year":"2008","unstructured":"Lai, C. Y. et al. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol. 82, 6631\u20136643 (2008).","journal-title":"J Virol."},{"key":"BFsrep19953_CR31","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1371\/journal.pntd.0000617","volume":"4","author":"JR Fried","year":"2010","unstructured":"Fried, J. R. et al. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis. 4, e617 (2010).","journal-title":"PLoS Negl Trop Dis."},{"key":"BFsrep19953_CR32","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1098\/rspb.2009.0331","volume":"276","author":"M Recker","year":"2009","unstructured":"Recker, M. et al. Immunological serotype interactions and their effect on the epidemiological pattern of dengue. Proc Biol Sci. 276, 2541\u20132548 (2009).","journal-title":"Proc Biol Sci."},{"key":"BFsrep19953_CR33","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1371\/journal.pntd.0000757","volume":"4","author":"TT Vu","year":"2010","unstructured":"Vu, T. T. et al. Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia. PLoS Negl Trop Dis. 4, e757 (2010).","journal-title":"PLoS Negl Trop Dis."},{"key":"BFsrep19953_CR34","doi-asserted-by":"publisher","first-page":"e1000129","DOI":"10.1371\/journal.pmed.1000129","volume":"6","author":"CP Simmons","year":"2009","unstructured":"Simmons, C. P. & Farrar, J. Changing patterns of dengue epidemiology and implications for clinical management and vaccines. PLoS Med. 6, e1000129 (2009).","journal-title":"PLoS Med."},{"key":"BFsrep19953_CR35","doi-asserted-by":"publisher","first-page":"e1000139","DOI":"10.1371\/journal.pmed.1000139","volume":"6","author":"DA Cummings","year":"2009","unstructured":"Cummings, D. A. et al. The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling. PLoS Med. 6, e1000139 (2009).","journal-title":"PLoS Med."},{"key":"BFsrep19953_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1590\/S1020-49892006001100007","volume":"20","author":"SB Halstead","year":"2006","unstructured":"Halstead, S. B. Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica. 20, 407\u2013415 (2006).","journal-title":"Rev Panam Salud Publica."},{"key":"BFsrep19953_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4269\/ajtmh.2001.65.180","volume":"65","author":"SB Halstead","year":"2001","unstructured":"Halstead, S. B. et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg. 65, 180\u2013183 (2001).","journal-title":"Am J Trop Med Hyg."},{"key":"BFsrep19953_CR38","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"MG Guzman","year":"2010","unstructured":"Guzman, M. G. et al. Dengue: a continuing global threat. Nat Rev Microbiol. 8, S7\u201316 (2010).","journal-title":"Nat Rev Microbiol."},{"key":"BFsrep19953_CR39","doi-asserted-by":"publisher","first-page":"e34602","DOI":"10.1371\/journal.pone.0034602","volume":"7","author":"H Chen","year":"2012","unstructured":"Chen, H. et al. Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice. PLoS One. 7, e34602 (2012).","journal-title":"PLoS One."},{"key":"BFsrep19953_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.imlet.2009.12.023","volume":"129","author":"N Gao","year":"2010","unstructured":"Gao, N. et al. Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral an anti-virus immunity after DNA vaccination. Immunol Lett. 129, 231 (2010).","journal-title":"Immunol Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep19953.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep19953","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep19953.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T23:40:52Z","timestamp":1672875652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep19953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,22]]}},"alternative-id":["BFsrep19953"],"URL":"https:\/\/doi.org\/10.1038\/srep19953","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,28]]},"assertion":[{"value":"21 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19953"}}